-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Innovation Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2010 to Q3 2023.
- Innovation Pharmaceuticals Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2023 was -$677K, a 14.4% increase year-over-year.
- Innovation Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$2.11M, a 66.5% increase from 2022.
- Innovation Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$6.28M, a 33.9% increase from 2021.
- Innovation Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$9.5M, a 128% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)